Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TMCI · as of Sep 30, 2025
Ownership Breakdown
119
Institutional Holders
▼ 5 vs Q2
$382.50M
Total Inst. Value
▲ $156.43M vs Q2
64.87M
Shares Outstanding
freeFloat 72.90%
57.04M
13F Shares Held
▲ 18.60M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TMCI largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
surgical & medical instruments & apparatus | 18.21M | 28.90% | 28.90% | $122.20B | Nov 12, 2025 | NEW |
ARMISTICE CAPITAL, LLC surgical & medical instruments & apparatus | 6.32M | 10.02% | 10.02% | $42.38B | Nov 17, 2025 | ▲ 56.0K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 3.68M | 5.84% | 5.84% | $24.71B | Nov 12, 2025 | ▼ 84.0K |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 3.63M | 5.77% | 5.77% | $24.39B | Nov 12, 2025 | ▲ 534.5K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 2.73M | 4.34% | 4.34% | $18.33B | Nov 7, 2025 | ▲ 6.2K |
GAGNON SECURITIES LLC surgical & medical instruments & apparatus | 2.26M | 3.58% | 3.58% | $15.15B | Nov 3, 2025 | ▲ 8.1K |
MILLENNIUM MANAGEMENT LLC surgical & medical instruments & apparatus | 1.71M | 2.71% | 2.71% | $11.48B | Nov 14, 2025 | ▲ 192.9K |
CIBC PRIVATE WEALTH GROUP, LLC surgical & medical instruments & apparatus | 1.69M | 2.68% | 2.68% | $11.32B | Nov 24, 2025 | ▼ 1.0K |
JPMORGAN CHASE & CO surgical & medical instruments & apparatus | 1.61M | 2.56% | 2.56% | $10.83B | Nov 26, 2025 | ▼ 163.7K |
FIRST EAGLE INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.24M | 1.97% | 1.97% | $8.31B | Nov 12, 2025 | ▲ 330.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
25
Increased
+1.81M shares4
New Positions
first time holders14
Decreased
−1.20M shares0
Sold Out
fully exitedNet shares change (top 50)
+613.4K
+1.81M / −1.20M
Net new holders
+15
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TMCI insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
14
Buy transactions
1
Sell transactions
14.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Treace John T. Chief Executive Officer | Jun 1, 2026 | Purchase | 50,000 | $3.56 | $177.9K | 7.32M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 28, 2026 | Purchase | 61,202 | $3.02 | $184.8K | 7.27M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 27, 2026 | Purchase | 49,810 | $2.87 | $143.2K | 7.21M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 26, 2026 | Purchase | 4,508 | $2.79 | $12.6K | 7.16M | Form 4 ↗ |
BAKEWELL JOHN K director | May 19, 2026 | Award | 30,000 | — | — | 204.1K | Form 4 ↗ |
Kiernan Jane E director | May 19, 2026 | Award | 30,000 | — | — | 93.9K | Form 4 ↗ |
Berry Lance A director | May 19, 2026 | Award | 30,000 | — | — | 74.6K | Form 4 ↗ |
Jain Deepti director | May 19, 2026 | Award | 30,000 | — | — | 100.2K | Form 4 ↗ |
HAMILTON LAWRENCE W director | May 19, 2026 | Award | 30,000 | — | — | 74.1K | Form 4 ↗ |
Hanna Betsy director | May 19, 2026 | Award | 30,000 | — | — | 75.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Treace Medical Concepts, Inc. (TMCI) is primarily owned by institutional investors, who hold approximately 87.9% of total shares outstanding. Company insiders own approximately 27.10%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Treace Medical Concepts, Inc. is , holding approximately 18.21 million shares — equal to 28.90% of outstanding shares — as of September 30, 2025.
A total of 119 institutional investors currently hold TMCI stock, with a combined institutional value of approximately $382,498,297 as of the most recent 13F filing period.
Frequently asked questions
TMCI ownershipTreace Medical Concepts, Inc. (TMCI) is primarily owned by institutional investors, who hold approximately 87.9% of shares. The largest shareholder is with a 28.90% stake. Company insiders hold 27.10%. Data sourced from SEC Form 13F as of September 30, 2025.